Edgestream Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,842
| Closed | -$1.53M | – | 1011 |
|
|
2024
Q3 | $1.53M | Buy |
+55,842
| New | +$1.53M | 0.07% | 473 |
|
|
2023
Q4 | – | Sell |
-39,855
| Closed | -$639K | – | 982 |
|
|
2023
Q3 | $639K | Buy |
39,855
+9,763
| +32% | +$157K | 0.05% | 530 |
|
|
2023
Q2 | $698K | Buy |
+30,092
| New | +$698K | 0.06% | 454 |
|
|
2022
Q3 | – | Sell |
-98,342
| Closed | -$1.79M | – | 563 |
|
|
2022
Q2 | $1.79M | Buy |
98,342
+63,233
| +180% | +$1.15M | 0.14% | 226 |
|
|
2022
Q1 | $885K | Sell |
35,109
-17,937
| -34% | -$452K | 0.07% | 345 |
|
|
2021
Q4 | $1.46M | Sell |
53,046
-11,817
| -18% | -$326K | 0.09% | 267 |
|
|
2021
Q3 | $2.09M | Sell |
64,863
-93,992
| -59% | -$3.03M | 0.13% | 231 |
|
|
2021
Q2 | $4.86M | Buy |
+158,855
| New | +$4.86M | 0.29% | 125 |
|